nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD5—eyelid—leprosy	0.0612	0.198	CbGeAlD
Pramipexole—HTR1B—trigeminal nerve—leprosy	0.0276	0.0892	CbGeAlD
Pramipexole—HTR1D—trigeminal nerve—leprosy	0.0268	0.0864	CbGeAlD
Pramipexole—HTR1B—cranial nerve—leprosy	0.0197	0.0636	CbGeAlD
Pramipexole—HTR1D—cranial nerve—leprosy	0.0191	0.0616	CbGeAlD
Pramipexole—HTR2A—trigeminal nerve—leprosy	0.0133	0.0429	CbGeAlD
Pramipexole—DRD1—nerve—leprosy	0.0125	0.0402	CbGeAlD
Pramipexole—HTR2A—cranial nerve—leprosy	0.00947	0.0306	CbGeAlD
Pramipexole—HTR2A—hindlimb—leprosy	0.00798	0.0258	CbGeAlD
Pramipexole—HTR1B—blood vessel—leprosy	0.00793	0.0256	CbGeAlD
Pramipexole—HTR1D—blood vessel—leprosy	0.00767	0.0248	CbGeAlD
Pramipexole—DRD2—nerve—leprosy	0.00736	0.0238	CbGeAlD
Pramipexole—ADRA2A—peripheral nervous system—leprosy	0.00732	0.0236	CbGeAlD
Pramipexole—HTR2A—appendage—leprosy	0.00685	0.0221	CbGeAlD
Pramipexole—HTR2A—peripheral nervous system—leprosy	0.00623	0.0201	CbGeAlD
Pramipexole—Ascites—Thalidomide—leprosy	0.00574	0.00831	CcSEcCtD
Pramipexole—Protein urine present—Dapsone—leprosy	0.00572	0.00828	CcSEcCtD
Pramipexole—DRD4—testis—leprosy	0.00567	0.0183	CbGeAlD
Pramipexole—Altered state of consciousness—Thalidomide—leprosy	0.00565	0.00818	CcSEcCtD
Pramipexole—Aphthous stomatitis—Thalidomide—leprosy	0.00556	0.00806	CcSEcCtD
Pramipexole—Grand mal convulsion—Thalidomide—leprosy	0.00548	0.00794	CcSEcCtD
Pramipexole—Cerebral ischaemia—Thalidomide—leprosy	0.0054	0.00782	CcSEcCtD
Pramipexole—Tongue discolouration—Thalidomide—leprosy	0.0054	0.00782	CcSEcCtD
Pramipexole—Sinus bradycardia—Thalidomide—leprosy	0.00532	0.0077	CcSEcCtD
Pramipexole—Peripheral vascular disorder—Thalidomide—leprosy	0.00532	0.0077	CcSEcCtD
Pramipexole—Nuchal rigidity—Thalidomide—leprosy	0.00503	0.00728	CcSEcCtD
Pramipexole—Skin exfoliation—Dapsone—leprosy	0.00486	0.00705	CcSEcCtD
Pramipexole—HTR2A—nerve—leprosy	0.00485	0.0157	CbGeAlD
Pramipexole—Sexual dysfunction—Thalidomide—leprosy	0.00465	0.00674	CcSEcCtD
Pramipexole—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00449	0.0065	CcSEcCtD
Pramipexole—Gastric ulcer—Thalidomide—leprosy	0.00449	0.0065	CcSEcCtD
Pramipexole—Enlargement abdomen—Thalidomide—leprosy	0.00434	0.00628	CcSEcCtD
Pramipexole—Deep vein thrombosis—Thalidomide—leprosy	0.00429	0.00621	CcSEcCtD
Pramipexole—Toothache—Thalidomide—leprosy	0.00429	0.00621	CcSEcCtD
Pramipexole—Psoriasis—Thalidomide—leprosy	0.00415	0.00601	CcSEcCtD
Pramipexole—Myasthenia—Thalidomide—leprosy	0.00415	0.00601	CcSEcCtD
Pramipexole—Oral candidiasis—Thalidomide—leprosy	0.00411	0.00595	CcSEcCtD
Pramipexole—HTR1D—eye—leprosy	0.00408	0.0132	CbGeAlD
Pramipexole—Embolism—Thalidomide—leprosy	0.00406	0.00589	CcSEcCtD
Pramipexole—Hypothyroidism—Thalidomide—leprosy	0.00406	0.00589	CcSEcCtD
Pramipexole—Tooth disorder—Thalidomide—leprosy	0.00402	0.00583	CcSEcCtD
Pramipexole—DRD3—nervous system—leprosy	0.00391	0.0126	CbGeAlD
Pramipexole—Intestinal obstruction—Thalidomide—leprosy	0.00383	0.00554	CcSEcCtD
Pramipexole—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00383	0.00554	CcSEcCtD
Pramipexole—HTR2A—blood vessel—leprosy	0.00381	0.0123	CbGeAlD
Pramipexole—Neuralgia—Thalidomide—leprosy	0.00375	0.00544	CcSEcCtD
Pramipexole—Thrombosis—Thalidomide—leprosy	0.00368	0.00534	CcSEcCtD
Pramipexole—Cyanosis—Thalidomide—leprosy	0.00368	0.00534	CcSEcCtD
Pramipexole—DRD5—nervous system—leprosy	0.00367	0.0118	CbGeAlD
Pramipexole—Nystagmus—Thalidomide—leprosy	0.00365	0.00529	CcSEcCtD
Pramipexole—Metrorrhagia—Thalidomide—leprosy	0.00365	0.00529	CcSEcCtD
Pramipexole—Hyperlipidaemia—Thalidomide—leprosy	0.00362	0.00524	CcSEcCtD
Pramipexole—Psychotic disorder—Dapsone—leprosy	0.00361	0.00523	CcSEcCtD
Pramipexole—Stupor—Thalidomide—leprosy	0.00349	0.00506	CcSEcCtD
Pramipexole—Skin ulcer—Thalidomide—leprosy	0.00335	0.00485	CcSEcCtD
Pramipexole—Hyperaesthesia—Thalidomide—leprosy	0.00332	0.00481	CcSEcCtD
Pramipexole—Nasopharyngitis—Dapsone—leprosy	0.00331	0.00479	CcSEcCtD
Pramipexole—HTR2B—skin of body—leprosy	0.00331	0.0107	CbGeAlD
Pramipexole—Muscular weakness—Dapsone—leprosy	0.00326	0.00473	CcSEcCtD
Pramipexole—Influenza—Dapsone—leprosy	0.0032	0.00463	CcSEcCtD
Pramipexole—Petechiae—Thalidomide—leprosy	0.00317	0.00459	CcSEcCtD
Pramipexole—Endocrine disorder—Thalidomide—leprosy	0.00315	0.00456	CcSEcCtD
Pramipexole—Pancreatitis—Dapsone—leprosy	0.00313	0.00454	CcSEcCtD
Pramipexole—Acne—Thalidomide—leprosy	0.0031	0.00449	CcSEcCtD
Pramipexole—Apnoea—Thalidomide—leprosy	0.00308	0.00446	CcSEcCtD
Pramipexole—DRD2—eye—leprosy	0.00308	0.00993	CbGeAlD
Pramipexole—Vasodilation—Thalidomide—leprosy	0.00297	0.0043	CcSEcCtD
Pramipexole—Amenorrhoea—Thalidomide—leprosy	0.00297	0.0043	CcSEcCtD
Pramipexole—Vasodilation procedure—Thalidomide—leprosy	0.00297	0.0043	CcSEcCtD
Pramipexole—Proteinuria—Thalidomide—leprosy	0.00297	0.0043	CcSEcCtD
Pramipexole—Accidental injury—Thalidomide—leprosy	0.00295	0.00427	CcSEcCtD
Pramipexole—Protein urine present—Thalidomide—leprosy	0.00293	0.00424	CcSEcCtD
Pramipexole—Photosensitivity reaction—Dapsone—leprosy	0.00292	0.00423	CcSEcCtD
Pramipexole—Musculoskeletal stiffness—Thalidomide—leprosy	0.00291	0.00421	CcSEcCtD
Pramipexole—Skin discolouration—Thalidomide—leprosy	0.00289	0.00418	CcSEcCtD
Pramipexole—Viral infection—Thalidomide—leprosy	0.00289	0.00418	CcSEcCtD
Pramipexole—Cellulitis—Thalidomide—leprosy	0.00287	0.00415	CcSEcCtD
Pramipexole—Hypocalcaemia—Thalidomide—leprosy	0.00285	0.00413	CcSEcCtD
Pramipexole—Herpes simplex—Thalidomide—leprosy	0.00283	0.0041	CcSEcCtD
Pramipexole—Oliguria—Thalidomide—leprosy	0.00283	0.0041	CcSEcCtD
Pramipexole—Hyperuricaemia—Thalidomide—leprosy	0.00281	0.00407	CcSEcCtD
Pramipexole—DRD1—nervous system—leprosy	0.0028	0.00905	CbGeAlD
Pramipexole—Neuropathy peripheral—Dapsone—leprosy	0.00279	0.00405	CcSEcCtD
Pramipexole—Leukocytosis—Thalidomide—leprosy	0.00278	0.00402	CcSEcCtD
Pramipexole—Dyskinesia—Thalidomide—leprosy	0.00278	0.00402	CcSEcCtD
Pramipexole—Hypercholesterolaemia—Thalidomide—leprosy	0.00276	0.00399	CcSEcCtD
Pramipexole—Hearing impaired—Thalidomide—leprosy	0.00274	0.00397	CcSEcCtD
Pramipexole—Bone pain—Thalidomide—leprosy	0.00272	0.00394	CcSEcCtD
Pramipexole—Sinusitis—Dapsone—leprosy	0.00267	0.00387	CcSEcCtD
Pramipexole—Gait disturbance—Thalidomide—leprosy	0.00267	0.00387	CcSEcCtD
Pramipexole—Blood uric acid increased—Thalidomide—leprosy	0.00266	0.00385	CcSEcCtD
Pramipexole—Coordination abnormal—Thalidomide—leprosy	0.00266	0.00385	CcSEcCtD
Pramipexole—Neck pain—Thalidomide—leprosy	0.00264	0.00382	CcSEcCtD
Pramipexole—Pulmonary embolism—Thalidomide—leprosy	0.00261	0.00378	CcSEcCtD
Pramipexole—Eructation—Thalidomide—leprosy	0.00256	0.00371	CcSEcCtD
Pramipexole—Pharyngitis—Dapsone—leprosy	0.00254	0.00368	CcSEcCtD
Pramipexole—Depressed level of consciousness—Thalidomide—leprosy	0.00252	0.00365	CcSEcCtD
Pramipexole—HTR2B—tendon—leprosy	0.00252	0.00812	CbGeAlD
Pramipexole—Colitis—Thalidomide—leprosy	0.0025	0.00363	CcSEcCtD
Pramipexole—Candida infection—Thalidomide—leprosy	0.00249	0.00361	CcSEcCtD
Pramipexole—Skin exfoliation—Thalidomide—leprosy	0.00249	0.00361	CcSEcCtD
Pramipexole—Neuropathy—Thalidomide—leprosy	0.00245	0.00355	CcSEcCtD
Pramipexole—Dry eye—Thalidomide—leprosy	0.00241	0.00349	CcSEcCtD
Pramipexole—Cramps of lower extremities—Thalidomide—leprosy	0.0024	0.00347	CcSEcCtD
Pramipexole—Tinnitus—Dapsone—leprosy	0.00239	0.00346	CcSEcCtD
Pramipexole—Oesophagitis—Thalidomide—leprosy	0.00238	0.00345	CcSEcCtD
Pramipexole—Rash maculo-papular—Thalidomide—leprosy	0.00237	0.00343	CcSEcCtD
Pramipexole—Gynaecomastia—Thalidomide—leprosy	0.00233	0.00338	CcSEcCtD
Pramipexole—Pulmonary oedema—Thalidomide—leprosy	0.00232	0.00336	CcSEcCtD
Pramipexole—Hypertonia—Thalidomide—leprosy	0.00229	0.00331	CcSEcCtD
Pramipexole—Hyperkinesia—Thalidomide—leprosy	0.00227	0.0033	CcSEcCtD
Pramipexole—HTR1B—nervous system—leprosy	0.00227	0.00733	CbGeAlD
Pramipexole—Sepsis—Thalidomide—leprosy	0.00226	0.00328	CcSEcCtD
Pramipexole—Euphoric mood—Thalidomide—leprosy	0.00224	0.00325	CcSEcCtD
Pramipexole—Erythema—Dapsone—leprosy	0.00223	0.00323	CcSEcCtD
Pramipexole—Lymphadenopathy—Thalidomide—leprosy	0.00222	0.00321	CcSEcCtD
Pramipexole—SLC22A1—nervous system—leprosy	0.00222	0.00716	CbGeAlD
Pramipexole—HTR1D—nervous system—leprosy	0.0022	0.0071	CbGeAlD
Pramipexole—Thrombophlebitis—Thalidomide—leprosy	0.00219	0.00317	CcSEcCtD
Pramipexole—HTR2C—nervous system—leprosy	0.00218	0.00703	CbGeAlD
Pramipexole—Diabetes mellitus—Thalidomide—leprosy	0.00218	0.00315	CcSEcCtD
Pramipexole—Gastroenteritis—Thalidomide—leprosy	0.00214	0.00309	CcSEcCtD
Pramipexole—Vascular purpura—Thalidomide—leprosy	0.00212	0.00307	CcSEcCtD
Pramipexole—Deafness—Thalidomide—leprosy	0.00212	0.00307	CcSEcCtD
Pramipexole—Eczema—Thalidomide—leprosy	0.00211	0.00305	CcSEcCtD
Pramipexole—Vision blurred—Dapsone—leprosy	0.0021	0.00304	CcSEcCtD
Pramipexole—Eye pain—Thalidomide—leprosy	0.0021	0.00304	CcSEcCtD
Pramipexole—Cardiac failure congestive—Thalidomide—leprosy	0.00209	0.00302	CcSEcCtD
Pramipexole—Injury—Thalidomide—leprosy	0.00206	0.00298	CcSEcCtD
Pramipexole—HTR2B—nervous system—leprosy	0.00204	0.0066	CbGeAlD
Pramipexole—Libido decreased—Thalidomide—leprosy	0.00204	0.00296	CcSEcCtD
Pramipexole—HTR2A—eye—leprosy	0.00203	0.00655	CbGeAlD
Pramipexole—Increased appetite—Thalidomide—leprosy	0.00202	0.00292	CcSEcCtD
Pramipexole—Amnesia—Thalidomide—leprosy	0.00202	0.00292	CcSEcCtD
Pramipexole—Vertigo—Dapsone—leprosy	0.002	0.0029	CcSEcCtD
Pramipexole—Atrial fibrillation—Thalidomide—leprosy	0.002	0.00289	CcSEcCtD
Pramipexole—Visual disturbance—Thalidomide—leprosy	0.002	0.00289	CcSEcCtD
Pramipexole—Dermatitis bullous—Thalidomide—leprosy	0.00198	0.00287	CcSEcCtD
Pramipexole—ADRA2C—tendon—leprosy	0.00198	0.00639	CbGeAlD
Pramipexole—Purpura—Thalidomide—leprosy	0.00196	0.00285	CcSEcCtD
Pramipexole—Arthritis—Thalidomide—leprosy	0.00195	0.00282	CcSEcCtD
Pramipexole—Cough—Dapsone—leprosy	0.00194	0.00282	CcSEcCtD
Pramipexole—Hypoglycaemia—Thalidomide—leprosy	0.00194	0.00281	CcSEcCtD
Pramipexole—Cardiac failure—Thalidomide—leprosy	0.00194	0.00281	CcSEcCtD
Pramipexole—Lethargy—Thalidomide—leprosy	0.00193	0.0028	CcSEcCtD
Pramipexole—Hyponatraemia—Thalidomide—leprosy	0.0019	0.00275	CcSEcCtD
Pramipexole—Osteoarthritis—Thalidomide—leprosy	0.00189	0.00274	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00189	0.00274	CcSEcCtD
Pramipexole—Pain in extremity—Thalidomide—leprosy	0.00189	0.00274	CcSEcCtD
Pramipexole—Diplopia—Thalidomide—leprosy	0.00189	0.00274	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Thalidomide—leprosy	0.00188	0.00272	CcSEcCtD
Pramipexole—Migraine—Thalidomide—leprosy	0.00186	0.0027	CcSEcCtD
Pramipexole—Affect lability—Thalidomide—leprosy	0.00186	0.0027	CcSEcCtD
Pramipexole—Psychotic disorder—Thalidomide—leprosy	0.00185	0.00268	CcSEcCtD
Pramipexole—HTR1A—nervous system—leprosy	0.00183	0.00592	CbGeAlD
Pramipexole—Face oedema—Thalidomide—leprosy	0.00183	0.00265	CcSEcCtD
Pramipexole—Cardiac arrest—Thalidomide—leprosy	0.0018	0.00261	CcSEcCtD
Pramipexole—Mood swings—Thalidomide—leprosy	0.00179	0.0026	CcSEcCtD
Pramipexole—Ataxia—Thalidomide—leprosy	0.00178	0.00258	CcSEcCtD
Pramipexole—Tachycardia—Dapsone—leprosy	0.00177	0.00257	CcSEcCtD
Pramipexole—Dehydration—Thalidomide—leprosy	0.00176	0.00255	CcSEcCtD
Pramipexole—Dry skin—Thalidomide—leprosy	0.00174	0.00251	CcSEcCtD
Pramipexole—Orthostatic hypotension—Thalidomide—leprosy	0.00173	0.00251	CcSEcCtD
Pramipexole—Hypokalaemia—Thalidomide—leprosy	0.00172	0.0025	CcSEcCtD
Pramipexole—Breast disorder—Thalidomide—leprosy	0.00171	0.00248	CcSEcCtD
Pramipexole—Cramp muscle—Thalidomide—leprosy	0.0017	0.00247	CcSEcCtD
Pramipexole—DRD2—testis—leprosy	0.00169	0.00545	CbGeAlD
Pramipexole—Muscular weakness—Thalidomide—leprosy	0.00167	0.00242	CcSEcCtD
Pramipexole—DRD2—nervous system—leprosy	0.00166	0.00534	CbGeAlD
Pramipexole—Abdominal distension—Thalidomide—leprosy	0.00165	0.00239	CcSEcCtD
Pramipexole—Insomnia—Dapsone—leprosy	0.00164	0.00238	CcSEcCtD
Pramipexole—ADRA2C—testis—leprosy	0.00164	0.00529	CbGeAlD
Pramipexole—Dysphagia—Thalidomide—leprosy	0.00164	0.00237	CcSEcCtD
Pramipexole—Influenza—Thalidomide—leprosy	0.00164	0.00237	CcSEcCtD
Pramipexole—ADRA2C—nervous system—leprosy	0.00161	0.0052	CbGeAlD
Pramipexole—Pancreatitis—Thalidomide—leprosy	0.0016	0.00232	CcSEcCtD
Pramipexole—Angina pectoris—Thalidomide—leprosy	0.00159	0.00231	CcSEcCtD
Pramipexole—ADRA2A—tendon—leprosy	0.00158	0.0051	CbGeAlD
Pramipexole—Bronchitis—Thalidomide—leprosy	0.00157	0.00228	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Thalidomide—leprosy	0.00152	0.0022	CcSEcCtD
Pramipexole—Pollakiuria—Thalidomide—leprosy	0.00151	0.00219	CcSEcCtD
Pramipexole—Erectile dysfunction—Thalidomide—leprosy	0.00151	0.00218	CcSEcCtD
Pramipexole—Photosensitivity reaction—Thalidomide—leprosy	0.00149	0.00216	CcSEcCtD
Pramipexole—Weight increased—Thalidomide—leprosy	0.00149	0.00216	CcSEcCtD
Pramipexole—Gastrointestinal pain—Dapsone—leprosy	0.00149	0.00215	CcSEcCtD
Pramipexole—Weight decreased—Thalidomide—leprosy	0.00148	0.00214	CcSEcCtD
Pramipexole—Hyperglycaemia—Thalidomide—leprosy	0.00148	0.00214	CcSEcCtD
Pramipexole—Pneumonia—Thalidomide—leprosy	0.00147	0.00213	CcSEcCtD
Pramipexole—Infestation NOS—Thalidomide—leprosy	0.00146	0.00211	CcSEcCtD
Pramipexole—Infestation—Thalidomide—leprosy	0.00146	0.00211	CcSEcCtD
Pramipexole—Drowsiness—Thalidomide—leprosy	0.00146	0.00211	CcSEcCtD
Pramipexole—Depression—Thalidomide—leprosy	0.00145	0.00211	CcSEcCtD
Pramipexole—Acute coronary syndrome—Thalidomide—leprosy	0.00144	0.00208	CcSEcCtD
Pramipexole—Body temperature increased—Dapsone—leprosy	0.00144	0.00208	CcSEcCtD
Pramipexole—Abdominal pain—Dapsone—leprosy	0.00144	0.00208	CcSEcCtD
Pramipexole—Renal failure—Thalidomide—leprosy	0.00143	0.00208	CcSEcCtD
Pramipexole—Neuropathy peripheral—Thalidomide—leprosy	0.00143	0.00207	CcSEcCtD
Pramipexole—Myocardial infarction—Thalidomide—leprosy	0.00143	0.00207	CcSEcCtD
Pramipexole—Conjunctivitis—Thalidomide—leprosy	0.00142	0.00205	CcSEcCtD
Pramipexole—Sweating—Thalidomide—leprosy	0.0014	0.00203	CcSEcCtD
Pramipexole—Haematuria—Thalidomide—leprosy	0.00139	0.00202	CcSEcCtD
Pramipexole—Epistaxis—Thalidomide—leprosy	0.00138	0.00199	CcSEcCtD
Pramipexole—Sinusitis—Thalidomide—leprosy	0.00137	0.00198	CcSEcCtD
Pramipexole—HTR2A—tendon—leprosy	0.00134	0.00434	CbGeAlD
Pramipexole—Bradycardia—Thalidomide—leprosy	0.00133	0.00193	CcSEcCtD
Pramipexole—Rhinitis—Thalidomide—leprosy	0.00131	0.0019	CcSEcCtD
Pramipexole—ADRA2A—testis—leprosy	0.00131	0.00422	CbGeAlD
Pramipexole—Hypoaesthesia—Thalidomide—leprosy	0.0013	0.00189	CcSEcCtD
Pramipexole—Pharyngitis—Thalidomide—leprosy	0.0013	0.00188	CcSEcCtD
Pramipexole—Urinary tract disorder—Thalidomide—leprosy	0.00129	0.00187	CcSEcCtD
Pramipexole—Oedema peripheral—Thalidomide—leprosy	0.00129	0.00187	CcSEcCtD
Pramipexole—ADRA2A—nervous system—leprosy	0.00128	0.00415	CbGeAlD
Pramipexole—Urethral disorder—Thalidomide—leprosy	0.00128	0.00186	CcSEcCtD
Pramipexole—Visual impairment—Thalidomide—leprosy	0.00126	0.00183	CcSEcCtD
Pramipexole—Eye disorder—Thalidomide—leprosy	0.00122	0.00177	CcSEcCtD
Pramipexole—Tinnitus—Thalidomide—leprosy	0.00122	0.00177	CcSEcCtD
Pramipexole—Cardiac disorder—Thalidomide—leprosy	0.00122	0.00176	CcSEcCtD
Pramipexole—Angiopathy—Thalidomide—leprosy	0.00119	0.00172	CcSEcCtD
Pramipexole—Immune system disorder—Thalidomide—leprosy	0.00118	0.00171	CcSEcCtD
Pramipexole—Mediastinal disorder—Thalidomide—leprosy	0.00118	0.00171	CcSEcCtD
Pramipexole—Chills—Thalidomide—leprosy	0.00118	0.0017	CcSEcCtD
Pramipexole—Alopecia—Thalidomide—leprosy	0.00116	0.00168	CcSEcCtD
Pramipexole—Vomiting—Dapsone—leprosy	0.00116	0.00167	CcSEcCtD
Pramipexole—Mental disorder—Thalidomide—leprosy	0.00115	0.00166	CcSEcCtD
Pramipexole—Malnutrition—Thalidomide—leprosy	0.00114	0.00165	CcSEcCtD
Pramipexole—Headache—Dapsone—leprosy	0.00114	0.00165	CcSEcCtD
Pramipexole—Flatulence—Thalidomide—leprosy	0.00112	0.00163	CcSEcCtD
Pramipexole—Tension—Thalidomide—leprosy	0.00112	0.00162	CcSEcCtD
Pramipexole—Dysgeusia—Thalidomide—leprosy	0.00112	0.00162	CcSEcCtD
Pramipexole—HTR2A—testis—leprosy	0.00111	0.00359	CbGeAlD
Pramipexole—Nervousness—Thalidomide—leprosy	0.00111	0.0016	CcSEcCtD
Pramipexole—Back pain—Thalidomide—leprosy	0.0011	0.0016	CcSEcCtD
Pramipexole—Muscle spasms—Thalidomide—leprosy	0.0011	0.00159	CcSEcCtD
Pramipexole—HTR2A—nervous system—leprosy	0.00109	0.00353	CbGeAlD
Pramipexole—Nausea—Dapsone—leprosy	0.00108	0.00156	CcSEcCtD
Pramipexole—Vision blurred—Thalidomide—leprosy	0.00107	0.00156	CcSEcCtD
Pramipexole—Tremor—Thalidomide—leprosy	0.00107	0.00155	CcSEcCtD
Pramipexole—Ill-defined disorder—Thalidomide—leprosy	0.00106	0.00153	CcSEcCtD
Pramipexole—Anaemia—Thalidomide—leprosy	0.00105	0.00153	CcSEcCtD
Pramipexole—Agitation—Thalidomide—leprosy	0.00105	0.00152	CcSEcCtD
Pramipexole—Malaise—Thalidomide—leprosy	0.00103	0.00149	CcSEcCtD
Pramipexole—Vertigo—Thalidomide—leprosy	0.00102	0.00148	CcSEcCtD
Pramipexole—Syncope—Thalidomide—leprosy	0.00102	0.00148	CcSEcCtD
Pramipexole—Leukopenia—Thalidomide—leprosy	0.00102	0.00148	CcSEcCtD
Pramipexole—Palpitations—Thalidomide—leprosy	0.00101	0.00146	CcSEcCtD
Pramipexole—Loss of consciousness—Thalidomide—leprosy	0.001	0.00145	CcSEcCtD
Pramipexole—Cough—Thalidomide—leprosy	0.000995	0.00144	CcSEcCtD
Pramipexole—Convulsion—Thalidomide—leprosy	0.000988	0.00143	CcSEcCtD
Pramipexole—Hypertension—Thalidomide—leprosy	0.000984	0.00143	CcSEcCtD
Pramipexole—Myalgia—Thalidomide—leprosy	0.000971	0.00141	CcSEcCtD
Pramipexole—Arthralgia—Thalidomide—leprosy	0.000971	0.00141	CcSEcCtD
Pramipexole—Chest pain—Thalidomide—leprosy	0.000971	0.00141	CcSEcCtD
Pramipexole—Anxiety—Thalidomide—leprosy	0.000967	0.0014	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000964	0.0014	CcSEcCtD
Pramipexole—Discomfort—Thalidomide—leprosy	0.000959	0.00139	CcSEcCtD
Pramipexole—Dry mouth—Thalidomide—leprosy	0.000949	0.00138	CcSEcCtD
Pramipexole—Confusional state—Thalidomide—leprosy	0.000938	0.00136	CcSEcCtD
Pramipexole—Oedema—Thalidomide—leprosy	0.00093	0.00135	CcSEcCtD
Pramipexole—Infection—Thalidomide—leprosy	0.000924	0.00134	CcSEcCtD
Pramipexole—Shock—Thalidomide—leprosy	0.000915	0.00133	CcSEcCtD
Pramipexole—Nervous system disorder—Thalidomide—leprosy	0.000913	0.00132	CcSEcCtD
Pramipexole—Thrombocytopenia—Thalidomide—leprosy	0.000911	0.00132	CcSEcCtD
Pramipexole—Tachycardia—Thalidomide—leprosy	0.000908	0.00132	CcSEcCtD
Pramipexole—Skin disorder—Thalidomide—leprosy	0.000904	0.00131	CcSEcCtD
Pramipexole—Hyperhidrosis—Thalidomide—leprosy	0.0009	0.0013	CcSEcCtD
Pramipexole—Anorexia—Thalidomide—leprosy	0.000887	0.00128	CcSEcCtD
Pramipexole—Hypotension—Thalidomide—leprosy	0.000869	0.00126	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Thalidomide—leprosy	0.000848	0.00123	CcSEcCtD
Pramipexole—Insomnia—Thalidomide—leprosy	0.000842	0.00122	CcSEcCtD
Pramipexole—Paraesthesia—Thalidomide—leprosy	0.000836	0.00121	CcSEcCtD
Pramipexole—Dyspnoea—Thalidomide—leprosy	0.00083	0.0012	CcSEcCtD
Pramipexole—Somnolence—Thalidomide—leprosy	0.000827	0.0012	CcSEcCtD
Pramipexole—Dyspepsia—Thalidomide—leprosy	0.000819	0.00119	CcSEcCtD
Pramipexole—Decreased appetite—Thalidomide—leprosy	0.000809	0.00117	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Thalidomide—leprosy	0.000803	0.00116	CcSEcCtD
Pramipexole—Fatigue—Thalidomide—leprosy	0.000802	0.00116	CcSEcCtD
Pramipexole—Constipation—Thalidomide—leprosy	0.000796	0.00115	CcSEcCtD
Pramipexole—Pain—Thalidomide—leprosy	0.000796	0.00115	CcSEcCtD
Pramipexole—Feeling abnormal—Thalidomide—leprosy	0.000767	0.00111	CcSEcCtD
Pramipexole—Gastrointestinal pain—Thalidomide—leprosy	0.000761	0.0011	CcSEcCtD
Pramipexole—Urticaria—Thalidomide—leprosy	0.000739	0.00107	CcSEcCtD
Pramipexole—Abdominal pain—Thalidomide—leprosy	0.000736	0.00107	CcSEcCtD
Pramipexole—Body temperature increased—Thalidomide—leprosy	0.000736	0.00107	CcSEcCtD
Pramipexole—Hypersensitivity—Thalidomide—leprosy	0.000686	0.000993	CcSEcCtD
Pramipexole—Asthenia—Thalidomide—leprosy	0.000668	0.000967	CcSEcCtD
Pramipexole—Pruritus—Thalidomide—leprosy	0.000658	0.000954	CcSEcCtD
Pramipexole—Diarrhoea—Thalidomide—leprosy	0.000637	0.000922	CcSEcCtD
Pramipexole—Dizziness—Thalidomide—leprosy	0.000615	0.000891	CcSEcCtD
Pramipexole—Vomiting—Thalidomide—leprosy	0.000592	0.000857	CcSEcCtD
Pramipexole—Rash—Thalidomide—leprosy	0.000587	0.00085	CcSEcCtD
Pramipexole—Dermatitis—Thalidomide—leprosy	0.000586	0.000849	CcSEcCtD
Pramipexole—Headache—Thalidomide—leprosy	0.000583	0.000844	CcSEcCtD
Pramipexole—Nausea—Thalidomide—leprosy	0.000553	0.000801	CcSEcCtD
